World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
135
Citations
86090
World Ranking
2030
National Ranking
1152

Overview

Michael D. Prados is affiliated with the University of California, San Francisco in the United States. Their research predominantly focuses on Medicine and Biochemistry, Genetics and Molecular Biology, with significant work particularly in Genetics, Molecular Biology, Neurology, Radiology, Nuclear Medicine and Imaging, and Immunology.

The main topics addressed in their research include Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics, Immunotherapy and Immune Responses, Radiomics and Machine Learning in Medical Imaging, Brain Metastases and Treatment, and Chromatin Remodeling and Cancer.

Michael D. Prados has contributed to numerous publications across various venues. The most frequent venues for their work are Neuro-Oncology, Journal of Clinical Oncology, bioRxiv (Cold Spring Harbor Laboratory), Neuro-Oncology Advances, and Zenodo (CERN European Organization for Nuclear Research).

Recent papers authored or co-authored by Michael D. Prados include:

  • Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma, 2020, JAMA Oncology
  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma, 2023, Journal of Clinical Oncology
  • Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group, 2020, The Lancet Oncology
  • Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma, 2020, Journal of Clinical Investigation
  • RNA aggregates harness the danger response for potent cancer immunotherapy, 2024, Cell

Frequently collaborating co-authors in their work include Sabine Mueller, Cassie Kline, Annette M. Molinaro, Adam Resnick, and Javad Nazarian.

Best Publications

  • Comprehensive genomic characterization defines human glioblastoma genes and core pathways

    Roger McLendon;Allan Friedman;Darrell Bigner;Erwin G. Van Meir

  • The Somatic Genomic Landscape of Glioblastoma

    Cameron W. Brennan;Roel G W Verhaak;Aaron McKenna;Benito Campos

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma

    Henry S. Friedman;Michael D. Prados;Patrick Y. Wen;Tom Mikkelsen

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

    Jeanette E Eckel-Passow;Daniel H Lachance;Annette M. Molinaro;Kyle M. Walsh

  • Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

    Ingo K. Mellinghoff;Maria Y. Wang;Igor Vivanco;Daphne A. Haas-Kogan

  • Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas

    Justin S. Smith;Edward F. Chang;Kathleen R. Lamborn;Susan M. Chang

  • A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

    W K A Yung;R E Albright;J Olson;R Fredericks

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials

    Eric T. Wong;Kenneth R. Hess;Mary Jo Gleason;Kurt A. Jaeckle

  • Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

    W. K.Alfred Yung;Michael D. Prados;Ricardo Yaya-Tur;Steven S. Rosenfeld

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • A hierarchy of self-renewing tumor-initiating cell types in glioblastoma

    Ruihuan Chen;Merry C. Nishimura;Stephanie M. Bumbaca;Samir Kharbanda

  • Prognostic factors for survival of patients with glioblastoma: Recursive partitioning analysis

    Kathleen R. Lamborn;Susan M. Chang;Michael D. Prados

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Variants in the CDKN2B and RTEL1 regions are associated with high grade glioma susceptibility

    Margaret Wrensch;Robert B. Jenkins;Jeffrey S. Chang;Ru Fang Yeh

  • Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib

    Daphne A. Haas-Kogan;Michael D. Prados;Tarik Tihan;David A. Eberhard

  • The somatic genomic landscape of glioblastoma

    Cameron W. Brennan;Roel G. W. Verhaak;Aaron Mckenna;Benito Campos

Frequent Co-Authors

Susan M. Chang
Susan M. Chang University of California, San Francisco
Kathleen R. Lamborn
Kathleen R. Lamborn University of California, San Francisco
Patrick Y. Wen
Patrick Y. Wen Harvard University
Mitchel S. Berger
Mitchel S. Berger University of California, San Francisco
Timothy F. Cloughesy
Timothy F. Cloughesy University of California, Los Angeles
William M. Wara
William M. Wara Kaiser Permanente
W. K. Alfred Yung
W. K. Alfred Yung The University of Texas MD Anderson Cancer Center
David A. Larson
David A. Larson University of California, San Francisco
Joanna J. Phillips
Joanna J. Phillips University of California, San Francisco
Lisa M. DeAngelis
Lisa M. DeAngelis Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a popular choice, there are alternative pathways and related online degrees that offer flexibility and diverse career options in healthcare. For registered nurses looking to advance their qualifications efficiently, the rn to bsn without clinicals route is a convenient option—allowing busy professionals to earn a bachelor's degree with fewer on-site requirements.

For those seeking advanced roles in nursing leadership or clinical practice, there are accelerated msn to dnp programs and easy dnp programs available online. These programs are designed to be more accessible and time-efficient, often providing a streamlined curriculum for experienced nurses to quickly earn a Doctor of Nursing Practice degree.

If you’re just starting out, accelerated lpn programs offer a fast track into practical nursing, allowing entry into the healthcare workforce with minimal delay. Exploring these pathways can help you find the right fit for your goals, schedule, and education level.

Best Scientists Citing Michael D. Prados

Trending Scientists

Recently Published Articles